NASDAQ Biotechnology Index (NBI) Companies by Market Cap
The NASDAQ Biotechnology Index (NBI) tracks 263 constituent companies with a combined market cap of $1.84 Trillion, covering the largest publicly traded companies in USA. This ranking lists all NBI index holdings ordered by market capitalization — from the largest index heavyweights to smaller constituents. Updated daily with live market data.
Total Market Cap (USD)
$1.84 Trillion
Constituent Companies
263
Index Country
USA
| Rank | Company | Weight (%) | Market Cap (USD) | Sector | Industry | Price | 24h Change |
|---|---|---|---|---|---|---|---|
| 151 |
Cullinan Oncology LLC
NASDAQ:CGEM |
% | $894.21 Million | Healthcare | Biotechnology | $15.53 | +0.45% |
| 152 |
Rigel Pharmaceuticals Inc
NASDAQ:RIGL |
% | $882.44 Million | Healthcare | Biotechnology | $49.08 | +0.74% |
| 153 |
Janux Therapeutics Inc
NASDAQ:JANX |
% | $878.78 Million | Healthcare | Biotechnology | $18.39 | -0.59% |
| 154 |
Monte Rosa Therapeutics Inc
NASDAQ:GLUE |
% | $878.73 Million | Healthcare | Biotechnology | $10.30 | -0.19% |
| 155 |
Corvus Pharmaceuticals Inc
NASDAQ:CRVS |
% | $858.87 Million | Healthcare | Biotechnology | $10.52 | +3.04% |
| 156 |
Theravance Biopharma Inc
NASDAQ:TBPH |
% | $854.78 Million | Healthcare | Biotechnology | $17.03 | +0.00% |
| 157 |
Ardelyx Inc
NASDAQ:ARDX |
% | $846.86 Million | Healthcare | Biotechnology | $3.28 | +0.31% |
| 158 |
Arbutus Biopharma Corp
NASDAQ:ABUS |
% | $836.01 Million | Healthcare | Biotechnology | $4.22 | +0.96% |
| 159 |
Sana Biotechnology Inc
NASDAQ:SANA |
% | $835.22 Million | Healthcare | Biotechnology | $2.79 | +0.00% |
| 160 |
Xencor Inc
NASDAQ:XNCR |
% | $827.65 Million | Healthcare | Biotechnology | $24.63 | +0.53% |
| 161 |
ArriVent BioPharma, Inc. Common Stock
NASDAQ:AVBP |
% | $824.92 Million | Healthcare | Biotechnology | $16.73 | +0.12% |
| 162 |
Kalvista Pharmaceuticals Inc
NASDAQ:KALV |
% | $820.37 Million | Healthcare | Biotechnology | $27.00 | +0.00% |
| 163 |
Phibro Animal Health Corporation
NASDAQ:PAHC |
% | $808.34 Million | Healthcare | Drug Manufacturers - Specialty & Generic | $38.30 | +2.41% |
| 164 |
Geron Corporation
NASDAQ:GERN |
% | $783.82 Million | Healthcare | Biotechnology | $1.23 | +0.82% |
| 165 |
Replimune Group Inc
NASDAQ:REPL |
% | $762.97 Million | Healthcare | Biotechnology | $13.42 | +2.91% |
| 166 |
Annexon Inc
NASDAQ:ANNX |
% | $746.94 Million | Healthcare | Biotechnology | $4.02 | +0.50% |
| 167 |
Lexicon Pharmaceuticals Inc
NASDAQ:LXRX |
% | $746.25 Million | Healthcare | Biotechnology | $1.68 | -4.55% |
| 168 |
Solid Biosciences LLC
NASDAQ:SLDB |
% | $736.64 Million | Healthcare | Biotechnology | $6.87 | +0.73% |
| 169 |
Esperion Therapeutics Inc
NASDAQ:ESPR |
% | $726.75 Million | Healthcare | Drug Manufacturers - Specialty & Generic | $3.18 | +0.00% |
| 170 |
Astria Therapeutics Inc
NASDAQ:ATXS |
% | $718.13 Million | Healthcare | Biotechnology | $5873.65 | +10.87% |
| 171 |
Pacific Biosciences of California
NASDAQ:PACB |
% | $714.91 Million | Healthcare | Medical Devices | $2.33 | +1.30% |
| 172 |
Collegium Pharmaceutical Inc
NASDAQ:COLL |
% | $698.29 Million | Healthcare | Drug Manufacturers - Specialty & Generic | $22.09 | -0.09% |
| 173 |
Olema Pharmaceuticals Inc
NASDAQ:OLMA |
% | $683.06 Million | Healthcare | Biotechnology | $7.82 | +0.00% |
| 174 |
Aura Biosciences Inc
NASDAQ:AURA |
% | $676.15 Million | Healthcare | Biotechnology | $6.54 | +0.54% |
| 175 |
Wave Life Sciences Ltd
NASDAQ:WVE |
% | $665.71 Million | Healthcare | Biotechnology | $3.46 | -0.29% |
| 176 |
Ironwood Pharmaceuticals Inc
NASDAQ:IRWD |
% | $631.22 Million | Healthcare | Drug Manufacturers - Specialty & Generic | $3.82 | -1.29% |
| 177 |
Silence Therapeutics PLC
NASDAQ:SLN |
% | $612.84 Million | Healthcare | Biotechnology | $9.86 | +3.57% |
| 178 |
CorMedix Inc
NASDAQ:CRMD |
% | $578.90 Million | Healthcare | Biotechnology | $7.38 | +0.82% |
| 179 |
OmniAb Inc.
NASDAQ:OABI |
% | $574.29 Million | Healthcare | Biotechnology | $4.79 | +2.79% |
| 180 |
Prime Medicine, Inc. Common Stock
NASDAQ:PRME |
% | $567.71 Million | Healthcare | Biotechnology | $3.99 | +11.45% |
| 181 |
Phathom Pharmaceuticals Inc
NASDAQ:PHAT |
% | $565.60 Million | Healthcare | Biotechnology | $7.25 | +1.68% |
| 182 |
Sage Therapeutics Inc
NASDAQ:SAGE |
% | $544.94 Million | Healthcare | Biotechnology | $8.68 | +0.00% |
| 183 |
Regenxbio Inc
NASDAQ:RGNX |
% | $532.73 Million | Healthcare | Biotechnology | $8.07 | -0.25% |
| 184 |
Aquestive Therapeutics Inc
NASDAQ:AQST |
% | $531.98 Million | Healthcare | Drug Manufacturers - Specialty & Generic | $4.78 | +0.42% |
| 185 |
Neurogene Inc
NASDAQ:NGNE |
% | $526.69 Million | Healthcare | Biotechnology | $26.40 | -0.38% |
| 186 |
Zevra Therapeutics Inc.
NASDAQ:ZVRA |
% | $516.25 Million | Healthcare | Biotechnology | $11.39 | +3.55% |
| 187 |
4D Molecular Therapeutics Inc
NASDAQ:FDMT |
% | $515.62 Million | Healthcare | Biotechnology | $13.33 | +4.96% |
| 188 |
Evolus Inc
NASDAQ:EOLS |
% | $510.57 Million | Healthcare | Drug Manufacturers - Specialty & Generic | $7.73 | -0.90% |
| 189 |
Arvinas Inc
NASDAQ:ARVN |
% | $484.55 Million | Healthcare | Biotechnology | $7.64 | +1.73% |
| 190 |
Autolus Therapeutics Ltd
NASDAQ:AUTL |
% | $481.75 Million | Healthcare | Biotechnology | $1.81 | +2.26% |
| 191 |
Prothena Corporation plc
NASDAQ:PRTA |
% | $475.86 Million | Healthcare | Biotechnology | $8.84 | +2.67% |
| 192 |
Iteos Therapeutics Inc
NASDAQ:ITOS |
% | $448.68 Million | Healthcare | Biotechnology | $10.15 | +0.00% |
| 193 |
Design Therapeutics Inc
NASDAQ:DSGN |
% | $430.65 Million | Healthcare | Biotechnology | $11.65 | +1.39% |
| 194 |
ARS Pharmaceuticals, Inc
NASDAQ:SPRY |
% | $420.04 Million | Healthcare | Biotechnology | $4.23 | -7.24% |
| 195 |
Editas Medicine Inc
NASDAQ:EDIT |
% | $414.67 Million | Healthcare | Biotechnology | $2.90 | +2.11% |
| 196 |
Atea Pharmaceuticals Inc
NASDAQ:AVIR |
% | $413.05 Million | Healthcare | Biotechnology | $5.15 | -0.10% |
| 197 |
Apellis Pharmaceuticals Inc
NASDAQ:APLS |
% | $412.48 Million | Healthcare | Biotechnology | $3.22 | +3.29% |
| 198 |
Y mAbs Therapeutics
NASDAQ:YMAB |
% | $391.22 Million | Healthcare | Biotechnology | $8.61 | +0.00% |
| 199 |
Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT |
% | $390.53 Million | Healthcare | Biotechnology | $13.74 | +6.76% |
| 200 |
C4 Therapeutics Inc
NASDAQ:CCCC |
% | $388.76 Million | Healthcare | Biotechnology | $3.16 | +10.88% |
Complete list of all companies in the NBI index ranked by market capitalization. Track index constituent performance and market values. View all indices